Professor Georgina Long AO BSc (Hons 1 UM), PhD, MBBS is Medical Director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research at MIA, Royal North Shore Hospital, and The University of Sydney. She leads a major clinical trials program and research laboratory focused on immuno-oncology and targeted therapies, with NHMRC-funded research centred on mechanisms of therapy resistance, and biomarkers of sensitivity.

Named 2024 Australian of the Year, Professor Long holds Fellowships with ASCO (2025), the Australian Academy of Science (2024), and FAHMS (2017), and was appointed an Officer of the Order of Australia (2020). Her honours include the Ramaciotti Medal for Biomedical Research and the Fulbright U.S. Mission Australia Award for Leadership Excellence (2024). She is a Clarivate Highly Cited Researcher with an H-index of 158 and over 650 publications in journals including the New England Journal of Medicine, Lancet, Nature, and Science.  She holds a PhD in Chemistry, and a Fulbright Postdoctoral Fellowship from Scripps Research Institute, USA.